The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of oral selective estrogen receptor degraders (SERD)s in the treatment of estrogen receptor positive (ER+), HER2-negative metastatic breast cancer (MBC): A stratified analysis of the ESR1 wild type (wt) and mutant (mt) subgroups.
 
Joseph J Zhao
No Relationships to Disclose
 
Nicky Wong Zhun Hong
No Relationships to Disclose
 
Dominic Wei Ting Yap
No Relationships to Disclose
 
Rebecca Jia Min Ong
No Relationships to Disclose
 
Raghav Sundar
Stock and Other Ownership Interests - Teladoc
Honoraria - AstraZeneca; Bristol-Myers Squibb; DKSH; Ipsen; Lilly; MSD; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; DKSH; Eisai; GlaxoSmithKline; Merck; MSD; Novartis; Taiho Pharmaceutical
Research Funding - MSD; Natera; Paxman
Travel, Accommodations, Expenses - AstraZeneca; DKSH; Eisai; Roche; Taiho Pharmaceutical
 
Joline Si Jing Lim
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; DKSH; Everest Medicine; MSD; Novartis; Pfizer
Research Funding - CTI BioPharma Corp (Inst)
Travel, Accommodations, Expenses - MSD
 
Shaheenah S. Dawood
Honoraria - Abbvie; AstraZeneca; biocon; Bristol-Myers Squibb; Caris Life Sciences; Celgene; Janssen-Cilag; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - MSD Oncology
Speakers' Bureau - AstraZeneca; Pfizer; Roche/Genentech
Research Funding - MSD Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Pfizer; Roche